Pharma Focus Asia
KP - Sustainable Packaging Solutions

APC and VLE Therapeutics Invests US$108 million (€100 million) to Open Medicine Campus in Dublin, Ireland

Introduction:

APC and VLE Therapeutics are investing US$108 million (€100 million) for the groundbreaking expansion of medicine accelerator campus in Dublin, Ireland.

Features:

The 130,000 square-foot campus, now the largest R&D site in Ireland's biopharmaceutical sector and the extended headquarters for APC and VLE, will incorporate the most recent advancements in scientific research, AI, neural networks, and scientifically guided manufacturing processes.

The latest expansion will elevate competitiveness by intensifying the integration of leading-edge advancements in sustainability, artificial intelligence, and groundbreaking science. 

This initiative will empower the team to reimagine and revolutionise the development and manufacturing processes of medicine.

With the inclusion of 300 new positions, the collective workforce will exceed 600 individuals, comprising scientists, digital experts, and manufacturing professionals. This expansion solidifies the team's presence on the global stage.

Specifications:

Name     APC and VLE Therapeutics
Type       New Construction
Budget   US$108 million (€100 million)


 

Latest Issue
Get instant
access to our latest e-book
MFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Gibco Adherent Kidney Media PanelCPHI Korea 2024Equinix accelerated medical research...CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?